The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
That blue finish is looking increasingly likely!
The mm’s don’t have anymore shares to sell today than they did yesterday, they may have walked us down over the last week but they still don’t have much stock if we see any sustained buying!
Drac I’m not sure that you can point to many Aim companies that have the level of financial support we do. It’s not like we are a lifestyle company, these funds are needed to progress the trials and if as we hope they continue to be positive the rewards could be huge!
Shall we just turn off the lights then?
Until we get to market how else are we going to fund the research?
I think this is the first time that news of a placing seems to have leaked before it’s actually happened though, going off the SP over the last week.
But that’s the biggest part of our problem, the market has decided they either don’t want our product or PC’s valuation of what we have is seriously over priced. Unfortunately until we actually make a sale as opposed to giving out samples any valuations are all pie in the sky.
It’s just a shame your post could have been written 12 months ago and still read the same.
We don’t have any customers and we don’t have a product anyone wants to buy, so I’m not sure where the valuation of 8x share price can possibly come from.
I’m wondering if the highlight of PC’s trip will be the Vegas strip or Disneyland, I’m sure he will post his pics on Twitter for us all to enjoy.
Following on from This weeks update -
https://www.proactiveinvestors.co.uk/companies/news/1012752/faron-pharmaceuticals-confirms-promising-results-from-first-cohort-1012752.html
“Accelerated approval pathway” I like the sound of that!
What price if we manage to go it alone and get something to market…then the numbers do start to look huge!
Let’s say currently our quickest route to market looks like Bexmab, does anyone fancy a stab it the dark guess at possible timescales to market?